Concord Medical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	905.31	889.85	833.2	889.21	738.99	809.7
Revenue Growth (YoY)	4.89%	6.80%	-6.30%	20.33%	-8.73%	6.02%
Cost of Revenue	788.02	780.23	731.06	780.11	670.5	745.3
Gross Profit	117.29	109.62	102.15	109.1	68.49	64.41
Selling, General & Admin	49.79	47.79	47.23	45	32.86	36.43
Operating Expenses	49.57	48.81	47.41	44.31	31.02	36.32
Operating Income	67.72	60.81	54.74	64.78	37.47	28.09
Interest Expense	-3.5	-3.55	-3.52	-3.51	-4.79	-6.3
Interest & Investment Income	4.27	3.99	2.87	0.9	1.03	0.79
Currency Exchange Gain (Loss)	-	-	-	0.02	-0.17	-0.39
Other Non Operating Income (Expenses)	0.28	1.06	0.03	0.26	-0.08	1.34
EBT Excluding Unusual Items	68.77	62.3	54.12	62.45	33.47	23.53
Gain (Loss) on Sale of Assets	0.33	0.15	0.41	1.69	9.16	1.85
Other Unusual Items	-	-	-	0.09	0.17	0.2
Pretax Income	69.1	62.45	54.53	64.22	42.79	25.57
Income Tax Expense	14.41	12.88	11.78	13.58	8.39	5.8
Earnings From Continuing Operations	54.69	49.57	42.74	50.64	34.4	19.77
Minority Interest in Earnings	0.04	-	-	0.02	-	-
Net Income	54.73	49.57	42.74	50.66	34.4	19.77
Net Income to Common	54.73	49.57	42.74	50.66	34.4	19.77
Net Income Growth	16.45%	15.97%	-15.62%	47.27%	73.96%	-36.99%
Shares Outstanding (Basic)	33	33	33	33	25	25
Shares Outstanding (Diluted)	33	33	33	33	25	25
Shares Change (YoY)	0.06%	0.07%	0.17%	33.03%	0.22%	-0.05%
EPS (Basic)	1.64	1.49	1.28	1.52	1.37	0.79
EPS (Diluted)	1.64	1.48	1.28	1.52	1.37	0.79
EPS Growth	16.31%	15.63%	-15.77%	10.93%	73.42%	-36.80%
Free Cash Flow	112.81	74.12	25.05	117.1	115.63	-9.58
Free Cash Flow Per Share	3.37	2.21	0.75	3.51	4.61	-0.38
Dividend Per Share	1.100	1.100	1.000	1.000	0.500	0.400
Dividend Growth	10.00%	10.00%	-	100.00%	25.00%	-
Gross Margin	12.96%	12.32%	12.26%	12.27%	9.27%	7.95%
Operating Margin	7.48%	6.83%	6.57%	7.29%	5.07%	3.47%
Profit Margin	6.05%	5.57%	5.13%	5.70%	4.66%	2.44%
Free Cash Flow Margin	12.46%	8.33%	3.01%	13.17%	15.65%	-1.18%
EBITDA	150.77	143.37	131.35	138.83	111.84	107.55
EBITDA Margin	16.65%	16.11%	15.76%	15.61%	15.13%	13.28%
D&A For EBITDA	83.05	82.56	76.61	74.05	74.37	79.46
EBIT	67.72	60.81	54.74	64.78	37.47	28.09
EBIT Margin	7.48%	6.83%	6.57%	7.29%	5.07%	3.47%
Effective Tax Rate	20.85%	20.62%	21.61%	21.15%	19.61%	22.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.